%0 Journal Article
%T Cervical HPV infection and related diseases among 149,559 women in Fujian: an epidemiological study from 2018 to 2023.
%A Lin K
%A Hong Q
%A Fu Y
%A Tu H
%A Lin H
%A Huang J
%A Hu Y
%A Huang M
%A Chen M
%J Front Microbiol
%V 15
%N 0
%D 2024
%M 38962121
%F 6.064
%R 10.3389/fmicb.2024.1418218
%X <B>UNASSIGNED: </B>To comprehensively analyze the epidemiological features of human papillomavirus (HPV) and HPV-related cervical diseases in females aged 35-64 years.<BR><B>UNASSIGNED: </B>A total of 149,559 samples of exfoliated cervical cells screened for HPV and related cervical lesions from January 2018 to December 2023 were enrolled. The prevalence of 15 high-risk and 6 low-risk HPV genotypes were detected, and the cervical cytology were analyzed. The impact of single and multiple HPV infections was characterized, and the effect of age was studied.<BR><B>UNASSIGNED: </B>The cervix cytology was normal in 86.60% of the females, while 7.13% of the females were diagnosed with cervix inflammation, 0.60% with ASC-US, 0.22% with ASC-H, 0.72% with LSIL, 0.49% with HSIL, 0.03% with ICC. The highest median age was observed in ASC-H group with 54 years old. Females with primary school education or lower have the highest positive rates. The overall HPV prevalence was 8.60%. The relatively prevalent HPV types were HPV52, 58, 16, 39, 51. HPV16, HPV18, HPV58, HPV33 and HPV52 were the top5 predominant types in ICC patients. 17.41% females suffered from multiple HPV infection with the most frequently co-infection subtypes being HPV52, HPV58 and HPV16. The prevalence of all HPV subtypes increased with age. Multiple HPV infections accounted for a larger proportion in those aged above 55 years. The peak HPV16 prevalence was observed in ICC group in cases aged 45-49 and 55-59. The peak HPV33 prevalence was observed in younger individuals aged 40-44 who developed ICC.<BR><B>UNASSIGNED: </B>More action should be taken against HPV33 infection.